New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical ...

Under the SEER classification system, "distant disease" and "stage 4 cancer" are synonymous. The one drawback to the SEER ...

Life expectancy for people with metastatic or metastasized lung cancer is low. The 5-year survival rate for small cell lung cancer is 3%, and 8% for non-small cell lung cancer (NSCLC). 25-30% of ...

Lung cancer rates vary by subtype and adenocarcinoma incidence worldwide, likely due to differences in air pollution, smoking, and generational patterns.

Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

When those primary cancer cells travel to your lungs, it’s called lung metastatic or secondary lung cancer. It’s a life-threatening condition. And it’s found in about a third of the people ...

Often, hyperechoic metastases correspond to hypervascular lesions, including metastases from renal cell carcinoma, breast carcinoma, and islet cell tumors (Fig. 6). Hypoechoic masses tend to be ...